In the News - Q1 Productions

This Week’s Headlines

Bionic Vision Secures Funding for “Bionic Eye” Development

Posted 4/5/2017

Bionic Vision has announced plans to move forward with development and commercialization of an implant which would enable partial treatment of retinitis pigmentosa, a genetic disease which breaks down rods overtime. The device will be comprised of an implant behind the retina to stimulate existing cells and an external camera and visual processing unit which transmits images to the implant. The “bionic eye” device is scheduled to begin clinical trials in Australia within the next few months. Read the full article here.

The European Union Announces New Medical Device Rules

Posted 4/5/2017

The EU has announced new regulations for medical devices to ensure safety and quality in European devices. The new rules will introduce an EU database listing all European devices and their progress in lifecycle development, device cards for patients to easily receive information regarding devices, and financial mechanisms which ensure that patients are fairly reimbursed in the event of defective products. Officials claim that the new rules are based off regulations introduced in 2012, and will focus on increasing patient safety and treatment quality. Read the full press release here.

Agenus Begins Advanced Cancer Vaccine Clinical Trials

Posted 4/5/2017

Agenus has commenced the first clinical trial of its latest advanced cancer treatment, AutoSynVax (ASV). Throughout the trial the neoantigen vaccine will be combined with QS-21 Stimulon. The treatment has presented evidence that it mediates tumor control and lasting immune memory in murine models of care. This success may be continued with checkpoint modifiers throughout clinical trial phases. Read the full press release here.

Medical Device and Diagnostic Industries to Experience Major Growth

Posted 4/5/2017

The medical device and diagnostic industries may experience a sharp growth between 2017 and 2025. Due to advancements in technology, reduced treatment cost, and recover time have aided the industry to expand treatment coverage and increase patient access. In addition to increasing access, strict global regulation has improved industry competition among device cost and quality. Though North America is currently the largest medical device market, Asia Pacific may soon become a strong competitor as it experiences notable economic growth. Read the full article here.

Teva Pharmaceuticals Releases Drug Metabolizing Innovation

Posted 4/5/2017

Teva Pharmaceuticals has announced an innovation in the way of drug metabolizing. To prolong therapy digestion and ensure drug abilities, Teva has begun replacing various hydrogen atoms within a drug with isotope deuterium. This heavier element, when introduced to a drug’s composition, allows the drug to remain unchanged for longer within the human body, increasing chances of therapy success. The isotope, commonly referred to a “heavier hydrogen,” increases the drug’s atomic weight which makes acidic breakdown more difficult. This has been primarily used in Teva’s Huntington disease therapy. Read the full article here.

At Veranex, we can help you with concept through to commercialization by enabling:
• Accelerated speed to market
• Controlled development costs
• Development risk mitigation
• Market viability assessment

At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions.

Visit Sponsor Website

Since TrainingPros was founded in 1997, we have been dedicated to helping our clients find the right consultant for their projects. 25 years later, we are proud to have helped hundreds of clients complete their projects and thousands of consultants find great assignments. We continue to focus on helping our clients and consultants as well as our community as a certified women-owned, award-winning staffing company that works exclusively with Learning & Development professionals to match consultants to client projects.

Visit Sponsor Website

TELCOR is the proven leader of health care software solutions for revenue cycle management (RCM) software and services designed specifically for laboratories. TELCOR RCM, our SaaS solution, and TELCOR Revenue Cycle Services, our billing service, are designed to streamline workflow, improve collections, and provide real-time analytics. Our software and service solutions are designed for the unique challenges and requirements of laboratory specialties and the clients they serve. With full access to data, labs have complete visibility of their data and can track key performance indicators. No other vendor works as hard ensuring you get paid for the work you do.

Visit Sponsor Website

At Tipping Point Media, we pride ourselves on developing innovative, creative, and technically advanced virtual training and digital marketing solutions for the life sciences industry.

We push the limits of what's possible using Augmented and Virtual Reality to create revolutionary experiences proven to increase audience engagement and retention rates.

Our dedicated team of educators, medical experts, certified programmers, and digital renaissance innovators are committed to creating high-quality custom creations that bring your company's vision to life.

Visit Sponsor Website

VantagePoint Performance trains Salespeople to be more fluent and comfortable across different situations needing different sales approaches, and we train Sales Managers to be better coaches and team leaders, with more focus and less stress.

We’re different from the average sales training company because:

We don’t believe that one approach, one system, or one methodology is absolutely superior. All have something to offer, and the “best approach” or “best system” depends on the sales situation. This is what our applied, academic research tells us.
Our use of data science, specifically Machine Learning, helps us learn about our clients more meaningfully. We provide insights from each client’s data to help them understand what drives the success of their top-performing Salespeople and Sales Managers.
We are constantly feeding what we learn back into our training products, and we invest a bigger slice of our total energy into this innovation than the average sales training company. Our clients can access always-refreshed intellectual property and content through our training subscriptions.

Visit Sponsor Website

Policy Reporter, acquired by TrialCard in 2019, provides innovative healthcare software solutions to track payer policies in near real-time and enhances market access for the therapies patients need most. The company’s patented software-driven solutions include a suite of billing and reimbursement tools for providers and laboratories, market intelligence tools for payers, and a suite of market access solutions for life science companies. Its clients include some of the world’s largest pharmaceutical and healthcare companies.

Visit Sponsor Website